Exparel 266 MG/20 ML vial 20ML
Ended Awarded
- Contract number
- SPE2DB25FDQVE
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $5,021
Award facts
- Contract value 100% obligated
- $5,021.26 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $5,021.26 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of EXPAREL 266 mg/20 ml vials. This firm fixed-price delivery order, awarded on May 30, 2025, with an ultimate completion date of June 23, 2025, was issued without set-aside designation. The award falls under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA under the SPE2DB program, a $499.999 billion vehicle valid through November 2026 that enables the agency to procure a comprehensive range of pharmaceutical products and medical supplies supporting Department of Defense healthcare facilities worldwide.
EXPAREL is a liposomal bupivacaine product used as a long-acting local anesthetic for pain management in surgical and medical settings. As a critical supplier in the federal pharmaceutical supply chain, DMS Pharmaceutical Group leverages its established IDC to fulfill individual delivery orders for branded and generic prescription drugs, biologics, and medical consumables to military health facilities. The company's consistent success in securing contracts with the DLA demonstrates its capability to reliably distribute specialized pharmaceutical products across the Department of Defense healthcare system.
Quick answers
Who was awarded contract SPE2DB25FDQVE?
SPE2DB25FDQVE was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on May 30, 2025.
How much is contract SPE2DB25FDQVE worth?
The government has obligated $5,021 on SPE2DB25FDQVE.
Is contract SPE2DB25FDQVE an order under another contract?
Yes. SPE2DB25FDQVE is a delivery order under SPE2DB24D9238, an indefinite delivery contract.
Was contract SPE2DB25FDQVE competed?
The extent of competition for SPE2DB25FDQVE was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award